On August 31, 2020, the government announced a $126 million investment to renovate the National Research Council, or NRC, facilities in Montreal. In February, NRC announced that construction of its new biologics facility on Royalmount Avenue in Montreal was expected to be completed by July. A few months of work would then be required to complete the facility, with the first engineering tests scheduled for December 2021. After that, production of Novavax's vaccine in Canada could begin.
Can you give us an update on this?